Top Stories
Biotech stocks pin bounce back hopes on M&A boost
By Amruta Khandekar and Leroy Leo (Reuters) – Plunging valuations have made biotech companies tempti...
12th August, 2022
By Amruta Khandekar and Leroy Leo (Reuters) – Plunging valuations have made biotech companies tempti...
12th August, 2022
By Kunal Kadiwar, Director, Results Healthcare The private equity community’s interest in healthcare...
25th October, 2018
TxCell set for phase I/II proof of principle clinical study in Q2 2015 for its second therapeutic ca...
1st November, 2014